Brought to you by 
Biopharmaceutical company GW Pharmaceuticals PLC nets $273.1mm in follow-on offering
10 Jun 2021
Executive Summary
GW Pharmaceuticals PLC netted $273.1mm in a follow-on public offering of 2.8mm American Depository Shares (ADSs; each ADS equals 12 ordinary shares) and the full exercise of the 420k over-allotment option at $90 per ADS. The company is developing a product portfolio of cannabinoid medicines for a wide range of indications.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Biopharmaceutical company GW Pharmaceuticals PLC nets $273.1mm in follow-on offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice